Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms

British Journal of Cancer

Volumn 75, Issue 4, 1997, Pages 545-547

  Kennedy, M M ^a   Lamb, D ^b   King, G ^a   Kerr, K M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; bcl 2; Cell loss factor; Immunohistochemistry; Lung carcinoma; Neuroendocrine; p53; Thymidine labelling index

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; THYMIDINE;

ARTICLE; CELL LOSS; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LUNG CANCER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031045265     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.95     Document Type: Article

References (25)

1. Ben-Ezra JM, Kornstein MJ, Grimes MM and Krystal G (1994) Small cell carcinomas of the lung express the bcl-2 protein. Am J Path, 145: 1036-1040
2. Collins VP, Leoffler RK and Tivey H (1956) Observation on growth rates of human tumours. Am J Roentgenol 76: 988-1000
3. Coltrera MD, Skelly M and Gown AM (1993) Anti-PCNA antibody PC10 yields unreliable proliferation indexes in routinely processed, deparaffinized. formalin-fixed tissue. Appl Immunohistochem 1: 193-200
4. Hall PA and Levison DA (1990) Review: assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192
5. Hall PA and Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry? - revisited. J Pathol 172: 1-4
6. Ikegaki N, Katsumata M, Minna J and Tsujimoto Y (1994) Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 54: 6-8
7. Jiang S-X, Sato Y, Kuwao S and Kameya T (1995) Expression of bcl-2 protein is prevalent in small cell carcinomas. J Pathol 177: 135-138
8. Ken KM and Lamb D (1984) Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br J Cancer 50: 343-349
9. Kerr KM, Robertson AMG and Lamb D (1983) In vitro thymidine labelling of human pulmonary neoplasms. Br J Cancer 47: 245-252
10. King G (1994) Microwave heating as a method of unmasking immunoglobulin light chain antigen in paraffin sections. UK NEQAS Immunocystochemistry News 3: 11-12
11. Lane DP (1993) A death in the life of p53, Nature 362: 786-787
12. Leek R, Kaklamanis L, Pezzella F, Gatter KC and Harris AL (1994) Bcl-2 in normal human breast and carcinoma association with oestrogen receptor positive. epidermal growth factor receptor-negative tumours and in situ cancers. Br J Cancer 69: 135-139
13. Lu Q-L, Abel P, Foster CS and Lalani E (1996) bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102-110
14. Miyashita T, Harigai M, Hanada M and Reed JC (1994a). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135
15. Miyashita T, Krajewski S, Krajewska M, Wang H-G, Lin H-K, Hoffman B, Lieberman D and Reed JC (1994b) Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
16. Park KO, Kim YC and Choi IS (1995) Relationship of bcl-2 gene expression and DNA ploidy, proliferative activity in non-small cell lung carcinoma. Am J Resp Crit Care Med 4: A277
17. Pezzella F, Turley H, Huzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC and Mason DY (1993) bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 329: 690-694
18. Piepentol JA and Vogelstein B (1993) No room at the p53 inn. Nature 365: 17-18
19. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B (1994) Paradoxical inhibition of solid tumour cell growth by bcl-2. Cancer Res 54: 3714-3717
20. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R and Pierotti MA (1994) Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172: 337-342
21. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F and Veronesi U (1994) The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients J Natl Cancer Inst 86: 499-504
22. Steel GG (1967) Cell loss as a factor in the growth rate of human tumours. Eur J Cancer 3: 381-387
23. Wiethege TH, Voss B and Muller K-M (1995) Positive PCNA status in lung tumour specimens correlates with p53 tumour suppressor gene accumulation. Am J Resp Crit Care Med 4: A278
24. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 88: 386-401
25. Yin X-M, Oltvai ZN and Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl 2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature, 369: 321-323